INTRODUCTION
============

The elderly have a higher prevalence of coronary artery disease (CAD) \[[@R1]\], this group of patients is progressively increasing. Despite the advantage of coronary artery revascularization in elderly patients \[[@R2]-[@R4]\], they have been steered towards percutaneous coronary intervention (PCI) as it is less invasive than coronary artery bypass graft (CABG) \[[@R5]\].

Minimally invasive coronary artery bypass (MICS-CABG) became an attractive technique for coronary revascularization. Studies have showed MICS--CABG is as effective as traditional sternotomy-based CABG \[[@R6]-[@R9]\]. It has the advantage of being less invasive with faster recovery and shorter hospital stays \[[@R10],[@R11]\].

We explored the long-term outcome of PCI *vs* MICS-CABG in an elderly population.

MATERIALS AND METHODOLOGY
=========================

From January 2005 to December 2009, 1454 elderly patients (age ≥75 years) were identified as having coronary artery revascularization for CAD at Staten Island University Hospital (Staten Island, New York). Our study only included patients with class I indications for CABG (*i.e.* patients with 3 vessels CAD, left main disease or 2 vessels disease with significant proximal left anterior descending lesion). In addition, patients had coronary revascularization by PCI or MICS-CABG. Those who underwent sternotomy-CABG, concomitant valve replacement/repair and prior history of PCI or CABG were excluded from the study. We followed all included patients until June 2013. The primary outcomes were all-cause mortality and rate of repeat revascularization.

After institutional review board approval, trained physicians using our hospital medical record retrieved demographic data, risk factors for CAD, co-morbidities, laboratory values, left ventricular ejection fraction, Canadian Cardiovascular Society (CCS) class and procedural information on each index case. Survival status was retrieved from our medical record and social security death index.

Statistics Analysis
-------------------

Patients were divided into 2 groups according to the type of procedure and the baseline characteristics of the 2 groups were compared using the chi-square test for categorical variables and independent sample t-test for continuous variables. The distributions of continuous and categorical variables were represented as mean ± standard deviation, and frequencies and percentages, respectively.

A multivariate Cox regression was performed to explain the association between mortality and several independent variables, which have a significant association with mortality or have a clinical importance. Survival analysis was conducted using Kaplan--Meier curves and the 2 groups were compared with the use of the log rank test. All statistical analyses were performed with the use of STATA version 13.0, College Station, Texas.

RESULTS
=======

There were 175 elderly patients, age ≥75 years, that underwent PCI or MICS-CABG who were included in the study. Among the entire cohort, 109 patients (62%) with mean age 80.6 ± 3.8 years underwent PCI and 66 patients (38%) underwent MICS-CABG with mean age 79.6 ± 3.8 years. In the PCI group, 84 patients received drug eluting stents (77%), 24 patients received bare metal stents (22%) and one patient received both types of stents. The mean number of stents used per patient was 1.5 ± 0.8. In MICS-CABG group, 54 patients (82%) underwent off-pump surgery; all patients underwent revascularization using left internal mammary artery (LIMA) as an arterial conduit and average number of grafts per patient was 2.5 ± 0.7.

Baseline characteristics are summarized in Table **[1](#T1){ref-type="table"}**. Patients who underwent MICS-CABG had a significantly higher history of dyslipidaemia (PCI-40% *vs* MICS-CABG-77%, P = 0.001) while patients with PCI had a significantly higher history of myocardial infarction (PCI-46% *vs* MICS-CABG-24%, P = 0.004) and higher usage of clopidogrel (PCI-93% *vs* MICS-CABG-74%, P = 0.001). The median follow-up was 4.9 years for all patients, 34 patients (31%) died in the PCI group and 14 patients (21%) died in the MICS-CABG group (P = 0.15). Fig. (**[1](#F1){ref-type="fig"}**) summarized the overall mortality outcomes in both groups.

The average length of stay in the hospital was significantly shorter in the PCI group, 4.3 ± 4.7 days, than in MICS-CABG group, 7.8 ± 7.4 days, (P \< 0.001). In addition, 5 patients (4.7%) in the PCI group were discharged to a rehabilitation facility compared with 29 patients (43.9%) in the MICS-CABG group (P \< 0.001).

During the entire follow-up, 16 patients (15%) in the PCI group needed repeat revascularization, compared with 2 patients (3%) in MICS-CABG group, (P = 0.014). The Kaplan-Meier curve showed no significant difference in overall survival between both groups (log rank P = 0.318) (Fig. **[2](#F2){ref-type="fig"}**).

By using a multivariate Cox-regression model for all-cause mortality among elderly patients, including all possible predictors of mortality, age and ejection fraction were the only predictors of mortality in our study population, but the type of the procedure was not predictive of mortality with a hazard ratio of 0.77 (CI 0.28-2.10) (Table **[2](#T2){ref-type="table"}**).

DISCUSSION
==========

In our study, we compared 2 different procedures for coronary revascularization, PCI and MICS-CABG, in elderly patients with an average age of 81 years. We found that patients that underwent PCI had similar long-term outcome as MICS-CABG, there was no significant difference between both groups regarding all-cause mortality (31% PCI *vs.* 21% MICS-CABG; P = 0.15) and the overall 5 year survival was similar on Kaplan-Meier curves. Patients who underwent PCI had shorter hospital stay and less discharge to rehabilitation facility but had a higher rate of repeat revascularization.

Many trials, including the SYNTAX (The synergy between percutaneous coronary intervention with Taxus and cardiac surgery) trial, comparing CABG with PCI showed all-cause mortality benefit and cardiac-related mortality benefit after CABG compared with PCI \[[@R12]-[@R16]\]. Similarly, the ASCERT (The American College of Cardiology Foundation and the Society of Thoracic Surgeons Database Collaboration on the Comparative Effectiveness of Revascularization Strategies) study was an observation study which showed that among elderly patients (age ≥65 years) with multivessel disease had lower mortality and a long term survival benefit after open thoracotomy CABG compared with PCI \[[@R17]\]. In addition, in a meta-analysis of 10 randomized trials Hlatky *et al.* demonstrated long term mortality benefit after CABG compared with PCI in elderly patients ≥65 years \[[@R18]\]. But, Alam \[[@R19]\], explored the outcome between PCI and CABG in elderly \>70 years after revascularization for unprotected left main coronary artery disease, and found no significant difference between both procedures regarding all-cause mortality.

Studies showed the rate of repeat revascularization is higher after PCI compared with CABG, in a meta-analysis of 9 observational studies, Benedetto \[[@R20]\] found the frequency of repeat revascularization was more than 3 times higher after PCI than CABG. Similarly, Bravata \[[@R21]\], in a systematic review of 22 randomized controlled trials found similar results after 5 years of follow up. Fosbøl \[[@R22]\] studied the rate of repeat revascularization in older adults with an average age of 73 years and found that advanced age has a lower rate of repeat revascularization after CABG. In addition, Harskamp \[[@R23]\] in a meta-analysis comparing minimally invasive CABG with PCI which in LAD disease only, found a higher rate of repeat revascularization after PCI. An angiographic patency study with consecutive patient undergoing MICS-CABG, showed patency of 100% for LIMA and 92% for all grafts, with 6 month computed tomography angiographic follow-up, conferring longevity to the CABG procedure and symptom free survival \[[@R10]\].

Elderly patients with CAD usually have co-morbid conditions and after sternotomy CABG they have a high incidence of complications and longer hospital stay than younger patients \[[@R24]-[@R27]\]. King \[[@R28]\] found the length of hospital stay after minimal invasive CABG and PCI is shorter than for sternotomy CABG; and Alam \[[@R19]\] found that elderly patients aged \>70 years had an average hospital stay of 4.2 days, but longer hospital stay after sternotomy CABG (8.3 days).

Quality of life is an important factor for the elderly. Bardakci \[[@R29]\], showed that octogenarians undergoing CABG are less likely to be discharged home compared with younger patients. Gopaldas \[[@R30]\], showed that 45% of elderly patients aged ≥80 years were transferred to rehabilitation or care facility after CABG. Although early recovery after MICS-CABG is a documented advantage over traditional CABG, not enough studies in the elderly have elucidated this.

Our study has several limitations. First, because of the small number of patients, we could not carry out a subgroup analysis to explore the effect of procedure in patients with left main disease or 3 vessels disease alone. However, we repeated the statistical analysis after adding patients with previous history of PCI and the results were similar. Secondly, this study is non-randomized and retrospective in nature, we cannot exclude the possibility of selection bias. Third, we explored all-cause mortality without considering cardiac causes of death. Using the social security death index and medical records to detect the mortality, could lead to missing some outcomes.

Among elderly patients who underwent coronary revascularization, there was no significant difference regarding long term all cause mortality or survival after MICS-CABG and PCI. However, patients who underwent PCI had shorter hospital stay and fewer discharges to rehabilitation facilities but they had higher rate of repeat revascularization. Further evaluation on a large scale in this group of patients is needed.
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###### Baseline characteristics according to the type of procedure (Percutaneous Coronary Intervention, \[PCI\] versus Minimal invasive cardiac surgery \[MICS-CABG\]) in patients ≥ 75 years-old.

  Variables                             PCI           MICS-CABG     P Value          
  ------------------------------------- ------------- ------------- --------- ------ -------
  Age (years)                           80.6 ± 3.8    79.6 ± 3.8    0.946            
  Male                                  59            54%           41        62%    0.3
  Body mass index (kg/m²)               28.3 ± 4.9    26.8 ± 4.8    0.976            
  Family history of CAD1                20            19%           18        27%    0.175
  Smoker                                37            34%           17        26%    0.256
  Hypertension                          86            79%           59        89%    0.074
  Diabetes mellitus                     36            33%           13        20%    0.057
  Dyslipidaemia                         44            40%           51        77%    0.001
  Peripheral arterial disease           10            9%            8         12%    0.615
  Renal failure on dialysis             3             3%            2         3%     0.915
  Myocardial infarction                 50            46%           16        24%    0.004
  Congestive heart failure              11            10%           4         6%     0.356
  History of cerebrovascular event      5             5%            6         9%     0.234
  COPD2                                 9             8%            10        15%    0.155
  Pre CCS3                              3.0 ± 0.9     2.4 ± 0.9     0.001            
  Class I                               0             0%            11        17%     
  Class II                              35            32%           31        47%     
  Class III                             39            36%           14        21%     
  Class IV                              34            31%           10        15%     
  Syntax score                          20.2 ± 7.3    22.9 ± 10.1   0.975            
  Ejection fraction (%)                 46.7 ± 12.6   42.9 ± 11.4   0.976            
  Preoperative creatinine (mg/dl)       1.3 ± 0.9     1.1 ± 0.4     0.944            
  Preoperative glucose (mg/dl)          146 ± 47      107 ± 38      1                
  Aspirin                               103           97%           64        97%    0.899
  Clopidogrel                           99            93%           49        74%    0.001
  Beta blocker                          81            76%           58        88%    0.066
  ACEI4 or ARBS5                        88            83%           60        91%    0.157
  Statin                                85            80%           63        95%    0.007
  Site of lesion                                                                     0.001
  Left main artery                      2             2%            3         5%      
  Two vessels, including proximal LAD   54            50%           12        18%     
  Three vessels                         53            49%           51        77%     
  Number of bypass grafts                                                            
  1                                                                 5         8%      
  2                                                                 30        45%     
  3                                                                 27        41%     
  4                                                                 4         6%      
  Type of stent                                                                       
  BMS6                                  24            22%                             
  DES7                                  84            77%                             
  Both                                  1             1%                              
  Internal mammary artery utilized                                  66        100%    
  Cardiopulmonary bypass                                            12        18%     

1 CAD denotes coronary artery disease

2 COPD denotes chronic obstructive pulmonary disease

3 CCS denotes Canadian Cardiovascular Society

4 ACEI denotes angiotensin converting enzyme inhibitor

5 ARBS denotes angiotensin II receptor blockers

6 BMS denotes bare metal stent

7 DES denotes drug eluting stent

###### Multivariate Cox regression model for all-cause mortality among patients with age ≥ 75 years old underwent coronary revascularization.

                             Hazard Ratio   95% Confidence Interval   *P*Value   
  -------------------------- -------------- ------------------------- ---------- -------
  PCI1 *vs.* MICS-CABG2      0.77           0.28                      2.10       0.616
  Age                        1.14           1.05                      1.25       0.002
  Gender (Male)              1.02           0.49                      2.15       0.949
  Dyslipidaemia              0.60           0.27                      1.36       0.226
  Smoking                    1.26           0.61                      2.60       0.527
  Diabetes mellitus          1.84           0.88                      3.83       0.106
  Hypertension               1.81           0.87                      3.81       0.115
  Myocardial infarction      2.00           0.97                      4.10       0.060
  Congestive heart failure   0.40           0.12                      1.30       0.128
  Ejection fraction          0.97           0.94                      1.00       0.028
  Preop CCS3                 0.73           0.46                      1.16       0.186
  Site of the lesion         1.81           0.87                      3.81       0.115
  Aspirin                    1.05           0.21                      5.23       0.955
  Clopidogrel                2.96           0.63                      13.86      0.167
  Beta blocker               2.02           0.23                      17.61      0.525
  ACEI4 or ARBS5             0.29           0.03                      2.67       0.277
  Statin                     2.56           0.79                      8.30       0.116

1 PCI denotes percutaneous coronary artery intervention

2 MICS CABG denotes minimal invasive cardiac surgery - coronary artery bypass graft

3 CCS denotes Canadian Cardiovascular Society

4 ACEI denotes angiotensin converting enzyme inhibitor

5 ARBS denotes angiotensin II receptor blockers
